Costs of US prescription opioid epidemic estimated at $78.5 billion

September 14, 2016
pills

Prescription opioid overdose, abuse, and dependence carries high costs for American society, with an estimated total economic burden of $78.5 billion, according to a study in the October issue of Medical Care.

Health care accounts for about one-third of costs attributable to the prescription opioid epidemic, while one-fourth of costs are borne by the public sector, according to the analysis by Curtis Florence, PhD, and colleagues of the National Center for Injury Prevention and Control. They hope their findings will help in understanding the economic impact of opioid overdose, abuse, and dependence, and in guiding strategies aimed at reducing the burden of the epidemic.

"More than 40 Americans die each day from overdoses involving prescription opioids. Families and communities continue to be devastated by the epidemic of prescription opioid overdoses." said CDC Director Tom Frieden, MD, MPH. "The rising cost of the epidemic is also a tremendous burden for the health care system."

Study Shows High Societal Costs of Opioid Epidemic

Using data from a wide range of sources, the researchers estimated the "monetized burden" of prescription opioid overdose, abuse, and dependence in the United States. Costs were analyzed from a societal perspective—including direct healthcare costs, costs related to loss productivity, and costs to the criminal justice system.

Based on the latest data, nearly two million Americans met criteria for prescription opioid abuse and dependence in 2013. In the same year, there were more than 16,000 deaths from prescription opioid overdose. Both figures were substantially higher than in 2007—the most recent previous year for which comprehensive estimates were available.

Aggregate costs for prescription , abuse, and dependence were estimated at over $78.5 billion (in 2013 dollars). Total spending for health care and substance abuse was over $28 billion, most of which ($26 billion) was covered by insurance.

In nonfatal cases, costs for lost productivity—including reduced productive hours and lost production for incarcerated individuals—were estimated at about $20 billion. Nearly two-thirds of the total economic burden was due to , , and lost productivity for nonfatal cases. Fatal overdoses—including costs related to healthcare and lost productivity—accounted for $21.5 billion.

Overall, nearly one-fourth of the aggregate economic burden was funded by public sources. That included costs funded by public insurance (Medicaid, Medicare, and veterans' programs) and other government sources for substance abuse treatment.

There were also $7.7 billion in criminal justice-related costs—nearly all borne directly by state and local governments. In addition, the authors note reduced tax revenues due to opioid-related productivity losses.

Dr. Florence and colleagues point out some important limitations of the data sources and methods used to estimate costs. The study can't measure all of the societal costs of the opioid epidemic—including the impact on quality of life for opioid-dependent people, or the pain and suffering of family members who have lost loved ones due to fatal overdose.

"The that we can identify, however, do help increase our understanding of the impact of the epidemic," the researchers conclude. "These estimates can assist decision makers in understanding the magnitude of adverse health outcomes associated with prescription opioid use such as overdose, abuse, and dependence."

Explore further: Researchers identify sharp rise in opioid-related hospitalizations, health care costs

More information: Curtis S. Florence et al. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013, Medical Care (2016). DOI: 10.1097/MLR.0000000000000625

Related Stories

Researchers identify sharp rise in opioid-related hospitalizations, health care costs

May 2, 2016
Infection is a serious complication of intravenous drug abuse and a major cause of illness and death among intravenous drug users. As the national problem of opioid abuse, including of heroin, continues to grow, new research ...

Opioid-related insurance claims rise 3,000 percent

August 3, 2016
(HealthDay)—The number of private health insurance claims for Americans addicted to opioids and heroin rose 3,203 percent from 2007 to 2014, according to a Fair Health report.

Pharmacist prescribes education as key to curbing opioid abuse

May 27, 2016
Technologies that make it harder for people to abuse opioids - like doctoring pills so that they produce unpleasant side effects if broken, crushed or injected—likely will have limited effectiveness in stemming the global ...

Prescription opioids involved in most overdoses seen in emergency departments

October 27, 2014
In a national study of hospital emergency department visits for opioid overdoses, 67.8 percent of the overdoses involved prescription opioids (including methadone), followed by heroin, other unspecified opioids and multiple ...

Drug monitoring programs reduce opioid deaths, study finds

June 22, 2016
The implementation of state prescription drug monitoring programs was associated with the prevention of approximately one opioid-related overdose death every two hours on average nationwide, according to a new Vanderbilt-led ...

State opioid laws appear to have no impact on prescribing for 1 vulnerable population

June 23, 2016
A new study by researchers from The Dartmouth Institute of Health Policy and Clinical Practice and UCLA School of Law found state laws aimed at curbing prescription opioid abuse have had no measurable effect on opioid use ...

Recommended for you

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

Opioid prescriptions from dentists linked to youth addiction risk

December 3, 2018
Teens and young adults who receive their initial opioid prescriptions from their dentists or oral surgeons are at increased risk for opioid addiction in the following year, a study from the Stanford University School of Medicine ...

Rise in meth and opioid use during pregnancy

November 29, 2018
Amphetamine and opioid use in pregnancy increased substantially over the last decade in the United States, a new Michigan Medicine-led study finds. And a disproportionate rise occurred in rural counties.

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

KelDude
not rated yet Sep 15, 2016
This is a perfect example of how "big pharma" can take over a society via the doctor community with free "incentives" the prescriptions keep on getting written. This is only an epidemic to the public and insurance payers but to big pharma its a profit boom and you will get no cooperation from them to slow down the rate of prescribing the crap.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.